Pay in 4 interest-free payments of $5.38 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
Exendin-4 (exenatide) became the first clinically-approved GLP-1R agonist (2005) for treatment of T2D
However, the approval of GLP-1s has also led to health care professionals facing several barriers in prescribing the medications, including prior authorization requests, the need for dose adjustments and drug shortages
Gholam MF, Liu LP, Searcy LA, Denslow ND, Alli AA
They make you feel full faster and longer
Methods This analysis mapped ICD-10 codes to the clinical criteria specified by CMS for the Medicare GLP-1 Bridge and utilized the 2023 20% Research Identifiable File (RIF) Medicare Fee-For-Service Claims and Medicare Advantage Encounter Data to create condition flags, along with the Part D Prescription Drug Event data to create a flag for GLP-1 use
:max_bytes(150000):strip_icc()/Health-GettyImages-2236560849-a1934f1e4c004a19835cb508d021388b.jpg)
